Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
31.6M
-
Shares change
-
-1.28M
-
Total reported value, excl. options
-
$518M
-
Value change
-
-$37.2M
-
Put/Call ratio
-
1.42
-
Number of buys
-
86
-
Number of sells
-
-43
-
Price
-
$16.41
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2016
164 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2016.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.6M shares
of 101M outstanding shares and own 31.36% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.22M shares), BlackRock Fund Advisors (2.05M shares), WADDELL & REED FINANCIAL INC (2.03M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.71M shares), JANUS CAPITAL MANAGEMENT LLC (1.64M shares), STATE STREET CORP (1.33M shares), BlackRock Institutional Trust Company, N.A. (1.29M shares), JPMORGAN CHASE & CO (1.28M shares), PRICE T ROWE ASSOCIATES INC /MD/ (926K shares), and FMR LLC (887K shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.